Melanocortin-1 Receptor Polymorphisms and Risk of Melanoma: Is the Association Explained Solely by Pigmentation Phenotype?
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Risk of cutaneous malignant melanoma (CMM) is increased in sun-exposed whites, particularly those with a pale complexion. This study was designed to investigate the relationship of the melanocortin-1 receptor (MC1R) genotype to CMM risk, controlled for pigmentation phenotype. We report the occurrence of five common MC1R variants in an Australian population-based sample of 460 individuals with familial and sporadic CMM and 399 control individuals-and their relationship to such other risk factors as skin, hair, and eye color; freckling; and nevus count. There was a strong relationship between MC1R variants and hair color and skin type. Moreover, MC1R variants were found in 72% of the individuals with CMM, whereas only 56% of the control individuals carried at least one variant (P<.001), a finding independent of strength of family history of melanoma. Three active alleles (Arg151Cys, Arg160Trp, and Asp294His), previously associated with red hair, doubled CMM risk for each additional allele carried (odds ratio 2.0; 95% confidence interval 1. 6-2.6). No such independent association could be demonstrated with the Val60Leu and Asp84Glu variants. Among pale-skinned individuals alone, this association between CMM and MC1R variants was absent, but it persisted among those reporting a medium or olive/dark complexion. We conclude that the effect that MC1R variant alleles have on CMM is partly mediated via determination of pigmentation phenotype and that these alleles may also negate the protection normally afforded by darker skin coloring in some members of this white population.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The melanocortin 1 receptor (MC1R), which signals through cAMP, is a melanocytic transmembrane receptor involved in pigmentation, adaptive tanning and melanoma resistance.”
From RETRACTED: PKA-Mediated Phosphorylation of ATR Promotes Recruitment of XPA to UV-Induced DNA Damage (2014) · cites this paper as Palmer et al., 2000
In the citing paper
“Cyclic adenosine 3′,5′-monophosphate (cAMP) is a critical intracellular signaling molecule that, in melanocytes, is robustly generated following interactions between the melanocortin 1 receptor (MC1R), a Gs-coupled cell surface receptor, and alpha melanocyte stimulating hormone (MSH)”
From RETRACTED: PKA-Mediated Phosphorylation of ATR Promotes Recruitment of XPA to UV-Induced DNA Damage (2014) · cites this paper as Palmer et al., 2000
Citations
Cites
A simple salting out procedure for extracting DNA from human nucleated cells
Miller, S. A., Dykes, D. D., & Polesky, H. F. (1988) · Nucleic Acids Research · doi:10.1093/nar/16.3.1215 · Cited by 20,330 · cited 2×
“After extraction of DNA by standard methods (Miller et al. 1988), the nested primer strategy, described elsewhere (Box et al. 1997), was used to obtain sufficient DNA for dot blotting and for identification of MC1R alleles.”
MethodWeir, B. S. (1997) · Biometrics · doi:10.2307/2533134 · Cited by 2,263 · cited 2×
“Pairwise linkage disequilibrium was assessed by use of the program ASSOCIATE 2.33 ( Ott 1996 ) and was quantified as the standardized pairwise disequilibrium coefficient (D0) (Weir 1996).”
MethodInfluentialValverde, P., Healy, E., Jackson, I., Rees, J. L., & Thody, A. J. (1995) · Nature Genetics · doi:10.1038/ng1195-328 · Cited by 999 · cited 4×
“The MC1R gene is remarkably polymorphic in whites (Valverde et al. 1995; Box et al. 1997; Smith et al. 1998), and there are several reasons to suggest that particular human MC1R alleles may be associated with increased CMM susceptibility.”
BackgroundInfluentialHEATH, A. C., BUCHOLZ, K. K., MADDEN, P. A. F., DINWIDDIE, S. H., SLUTSKE, W. S., BIERUT, L. J., STATHAM, D. J., DUNNE, M. P., WHITFIELD, J. B., & MARTIN, N. G. (1997) · Psychological Medicine · doi:10.1017/s0033291797005643 · Cited by 831 · cited 2×
“The second control group comprised 181 unrelated individuals, sampled at random from 3,300 participants in a twin study of the inheritance of alcohol use, who had been drawn from the Australian Twin Registry (Heath et al. 1997).”
BackgroundSelf-citationWood, W. I., Gitschier, J., Lasky, L. A., & Lawn, R. M. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.6.1585 · Cited by 790
Eath, A. C. H., Ucholz, K. K. B., Adden, P. A. F. M., Inwiddie, S. H. D., Lutske, W. S. S., Ierut, L. J. B., Tatham, D. J. S., Hitfield, J. B. W., & Artin, N. G. M. (1997) · Cited by 423
Mechanisms of Ultraviolet Light‐Induced Pigmentation
Gilchrest, B. A., Park, H., Eller, M. S., & Yaar, M. (1996) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1996.tb02988.x · Cited by 364 · cited 1×
“During exposure of the skin to UV light, there is an increase in melanin production, through the tanning response, that may occur via an increase in tyrosinase gene transcription and enzyme activity (Gilchrest et al. 1996; Sturm 1998).”
BackgroundCharacterization of Melanocyte Stimulating Hormone Receptor Variant Alleles in Twins with Red Hair
Box, N. F., Wyeth, J. R., O'Gorman, L. E., Martin, N. G., & Sturm, R. A. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1891 · Cited by 340 · cited 9×
“Variants in the MC1R gene have previously been shown to be associated with red hair, pale skin, and freckling (Valverde et al. 1995; Box et al. 1997; Smith et al. 1998), and two groups have examined the relationship between particular MC1R variants and CMM.”
BackgroundMethodInfluentialSelf-citationThe Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma
Valverde, P. (1996) · Human Molecular Genetics · doi:10.1093/hmg/5.10.1663 · Cited by 304 · cited 5×
“By contrast, the alternative hypotheses are either that pheomelanin, its precursors, or photoproducts are mutagenic (Sturm 1998) or, possibly, that, as suggested by Valverde et al. (1996), this melanocortin receptor is involved in modulation of melanocyte growth and differentiation.”
BackgroundInfluentialGarbe, C., Krüger, S., Orfanos, C. E., Büttner, P., Weiß, J., Soyer, H. P., Stocker, U., Roser, M., Weckbecker, J., Panizzon, R., et al. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12374280 · Cited by 288 · cited 2×
“1997), with lighter skin tones and red hair color significantly increasing the risk of melanoma (Garbe et al. 1994; Grange et al. 1995; Grulich et al. 1996).”
Background
Research works printed but not linked: 1
- Frants, 1996, Melanocyte-stimulating hormone receptor (MC1R) variants modify melanoma risk in Dutch FAMMM families, Am J Hum Genet Suppl, 59, A67
Cited by
Items 201–300 of 508
Hacker, E., Nagore, E., Cerroni, L., Woods, S. L., Hayward, N. K., Chapman, B. M., Montgomery, G. W., Soyer, H. P., & Whiteman, D. C. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.385 · Cited by 44
“The melanocortin-1 receptor (MC1R) gene is a key determinant of human pigmentation, with specific variants linked to red hair and melanoma risk (Palmer et al., 2000; Sturm et al., 2003).”
BackgroundSelf-citationMinder, E. I. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.535515 · Cited by 44
“Besides melanization, MC1R signaling further protects skin cells from harmful effects of UV radiation [54-58]: Synthesis of anti-oxidative enzymes is propagated [47,48,59], cell cycle is arrested and xeroderma pigmentosum group A protein 1 is activated enabling repair processes [55,58] as illustrated by reduced levels…”
BackgroundMößner, R., Anders, N., König, I. R., Krüger, U., Schmidt, D., Berking, C., Ziegler, A., Brockmöller, J., Kaiser, R., Volkenandt, M., et al. (2006) · Archives of Dermatological Research · doi:10.1007/s00403-006-0708-7 · Cited by 42
A polymorphism in the agouti signalling protein (ASIP) is associated with decreased levels of mRNA
Voisey, J., Gomez‐Cabrera, M. D. C., Smit, D. J., Leonard, J. H., Sturm, R. A., & Van Daal, A. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00301.x · Cited by 40
Self-citationCust, A. E., Goumas, C., Holland, E. A., Agha‐Hamilton, C., Aitken, J. F., Armstrong, B. K., Giles, G. G., Kefford, R. F., Schmid, H., Hopper, J. L., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.27357 · Cited by 43
“7 Pigmentation score(4) 1st quartile (low-risk) 49 (9) 103 (25) 25 (8) 130 (25) 2nd quartile 130 (23) 102 (25) 59 (18) 129 (25) 3rd quartile 146 (26) 102 (25) 76 (23) 130 (25) 4th quartile (high-risk) 240 (42) 102 (25) 168 (51) 129 (25) p-value(2) <0.”
Self-citationStefanaki, I., Panagiotou, O. A., Kodela, E., Gogas, H. J., Kypreou, K. P., Chatzinasiou, F., Nikolaou, V. A., Plaka, M., Kalfa, I., Antoniou, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0055712 · Cited by 42
“The most prevalent low penetrance locus is the melanocortin 1 receptor gene (MC1R), whose variants have been associated both with melanoma [11–18] as well as with related traits [11,19–21].”
BackgroundHost Phenotype Characteristics and MC1R in Relation to Early-Onset Basal Cell Carcinoma
Ferrucci, L. M., Cartmel, B., Molinaro, A. M., Gordon, P. B., Leffell, D. J., Bale, A. E., & Mayne, S. T. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.402 · Cited by 41
“One study of BCC (Dwyer et al., 2004) and several of melanoma (Dwyer et al., 2004; Ichii-Jones et al., 1998; Kanetsky et al., 2010; Landi et al., 2005; Palmer et al., 2000) had findings similar to ours.”
BackgroundResultInfluentialAssociation between health-service use and multiplex genetic testing
Reid, R. J., McBride, C. M., Alford, S. H., Price, C. S., Baxevanis, A. D., Brody, L. C., & Larson, E. B. (2012) · Genetics in Medicine · doi:10.1038/gim.2012.52 · Cited by 42
Molecular landscape of Hereditary Melanoma
Arnaut, J. R. M. B., Guimarães, I. D. S., dos Santos, A. C. E., da Silva, F. D. M. L., Machado, J. R. D. S., & de Melo, A. C. (2021) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2021.103425 · Cited by 43
Common variants of DNA repair genes and malignant melanoma
Dębniak, T., Scott, R. J., Górski, B., Cybulski, C., van de Wetering, T., Serrano‐Fernández, P., Huzarski, T., Byrski, T., Nagay, L., Dębniak, B., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.10.006 · Cited by 41
MC1R common variants, CDKN2A and their association with melanoma and breast cancer risk
Dębniak, T., Scott, R. J., Masojć, B., Serrano‐Fernández, P., Huzarski, T., Byrski, T., Dębniak, B., Górski, B., Cybulski, C., Mędrek, K., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22210 · Cited by 41
“Feature Carriers (1) Non-carriers (2) p-Value 95% CI OR”
BackgroundSánchez‐Más, J., Guillo, L. A., Zanna, P. T., Jiménez‐Cervantes, C., & García-Borrón, J. C. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0227 · Cited by 41
Barón, A. E., Asdigian, N. L., Gonzalez, V., Aalborg, J., Terzian, T., Stiegmann, R. A., Torchia, E. C., Berwick, M., Dellavalle, R. P., Morelli, J. G., et al. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0633 · Cited by 42
“Moreover,MC1R R/þ subjects are known to be at elevated risk for melanoma (40).”
BackgroundSelf-citationZhi-qiang, D., Silvia, V., Gilbert, H., Vignoles, F., Créchet, F., Shimogiri, T., Yasue, H., Jean‐Jacques, L., Stephan, B., Joseph, G., et al. (2006) · International Journal of Cancer · doi:10.1002/ijc.22289 · Cited by 40
Leonard, J. H., Marks, L. H., Chen, W., Cook, A. L., Boyle, G. M., Smit, D. J., Brown, D. L., Stow, J. L., Parsons, P. G., & Sturm, R. A. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00033.x · Cited by 39
Self-citationBehind the Scene: Exploiting MC1R in Skin Cancer Risk and Prevention
Manganelli, M., Guida, S., Ferretta, A., Pellacani, G., Porcelli, L., Azzariti, A., & Guida, G. (2021) · Genes · doi:10.3390/genes12071093 · Cited by 41
Ghiorzo, P., Bonelli, L. A., Pastorino, L., Bruno, W., Barile, M., Andreotti, V., Nasti, S., Battistuzzi, L., Grosso, M., Bianchi‐Scarrà, G., et al. (2012) · Experimental Dermatology · doi:10.1111/j.1600-0625.2012.01549.x · Cited by 38
Recent Advances in the Biology, Therapy and Management of Melanoma
Davids, L. M. (2013) · InTech eBooks · doi:10.5772/46052 · Cited by 38
Soufir, N., Lacapère, J.-J., Bertrand, G., Matichard, E., Meziani, R., Mirebeau‐Prunier, D., Descamps, V., Gérard, B., Archimbaud, A., Ollivaud, L., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601503 · Cited by 41
“…environmental factors such as high sun exposure has been shown in several studies, depending upon polymorphisms located on genes controlling DNA repair (Winsey et al, 2000), pigmentation (Palmer et al, 2000), and reactive oxygen detoxification pathways (Strange et al, 1999; Kanetsky et al, 2001).”
BackgroundHenri, P., Beaumel, S., Guezennec, A., Poumès‐Ballihaut, C., Stoebner, P., Stasia, M. J., Guesnet, J., Martínez, J., & Meunier, L. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22996 · Cited by 41
“…cells should be interpreted with caution since this cell line presents several abnormalities including p53 double mutation, p16 promoter hypermethylation, and alterations in some of the molecular events necessary for NF-kB activation (Chaturvedi et al., 1999; Qin et al., 1999; Lewis et al., 2006).”
BackgroundMelanocortin Signalling Mechanisms
Eves, P. C., & Haycock, J. W. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6354-3_2 · Cited by 40
Chapter 4 The Melanocortin‐1 Receptor Gene Polymorphism and Association with Human Skin Cancer
Beaumont, K. A., Liu, Y. Y., & Sturm, R. A. (2009) · Progress in molecular biology and translational science · doi:10.1016/s1877-1173(09)88004-6 · Cited by 46
Self-citationThe Pro162 Variant is a Loss-of-Function Mutation of the Human Melanocortin 1 Receptor Gene
Jiménez‐Cervantes, C., Olivares, C., González, P., García-Borrón, J. C., Morandini, R., & Ghanem, G. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01393.x · Cited by 38
Sharma, P., Bhunia, S., Poojary, S. S., Tekcham, D. S., Barbhuiya, M. A., Gupta, S., Shrivastav, B. R., & Tiwari, P. K. (2016) · Tumor Biology · doi:10.1007/s13277-016-5355-9 · Cited by 38
A Risk Prediction Tool for Melanoma?
Whiteman, D. C., & Green, A. C. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-4-ed · Cited by 36
“Whereas particular variants of MC1R have been strongly linked to fair skin, it seems that these variants may substantially increase the risk of melanoma when present in persons of olive skin color who might otherwise be considered to be at low risk (23).”
BackgroundSelf-citationNucleotide diversity and population differentiation of the Melanocortin 1 Receptor gene, MC1R
Savage, S. A., Gerstenblith, M. R., Goldstein, A. M., Mirabello, L., Fargnoli, M. C., Peris, K., & Landi, M. T. (2008) · BMC Genetics · doi:10.1186/1471-2156-9-31 · Cited by 36
“Several MC1R variants are also associated with increased risk of malignant melanoma in a variety of populations [14-22] The effect of MC1R polymorphisms in melanoma risk appears to extend Published: 10 April 2008”
BackgroundGenetics of familial and sporadic melanoma: Clinical dermatology • Review article
Bataille, V. A. (2000) · Clinical and Experimental Dermatology · doi:10.1046/j.1365-2230.2000.00689.x · Cited by 36
Effect of MELANOTAN®, [Nle4, D-Phe7]-α-MSH, on melanin synthesis in humans with MC1R variant alleles
FitzGerald, L. M., Fryer, J. L., Dwyer, T., & Humphrey, S. M. (2006) · Peptides · doi:10.1016/j.peptides.2004.12.038 · Cited by 35
Na, G. Y., Lee, K. H., Kim, M. K., Lee, S., Kim, D. W., & Kim, J. C. (2003) · Pigment Cell Research · doi:10.1034/j.1600-0749.2003.00062.x · Cited by 35
The genetics of malignant melanoma
Lomas, J., Martín‐Duque, P., Pons, M., & Quintanilla, M. (2008) · Frontiers in bioscience · doi:10.2741/3065 · Cited by 42
“Since certain MC1R polymorphic variants are associated with these characteristics and with a diminished ability of the epidermis to respond to UV damage, this pigment regulating gene is seen as a low-penetrance melanoma susceptibility gene (12-14).”
BackgroundHacker, E., Boyce, Z., Kimlin, M. G., Wockner, L. F., Pollak, T., Vaartjes, S. A., Hayward, N. K., & Whiteman, D. C. (2013) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12157 · Cited by 36
“Of these, MC1R is the gene most strongly associatedwithmelanoma risk (OR 1.4–2.4) (Palmer et al., 2000; Sturm et al., 2003).”
BackgroundSelf-citationGene polymorphisms and their effects in the melanocortin system
Carroll, L. J., Voisey, J., & van Daal, A. (2005) · Peptides · doi:10.1016/j.peptides.2004.12.031 · Cited by 37
Neuroendocrine Factors in Melanoma Pathogenesis
Scheau, C., DRAGHICI, C. C., Ilie, M. A., Lupu, M., Solomon, I., Tampa, M. Ş., Georgescu, S. R., Căruntu, A., Constantin, C., Neagu, M. T., et al. (2021) · Cancers · doi:10.3390/cancers13092277 · Cited by 36
“Different variants of the MC1R gene have been identified in normal skin and melanoma, and a deterministic connection between alleles of this gene and the susceptibility to melanoma has been suggested, but studies show controversial results [168,174,175].”
ResultA dynamic interface between ubiquitylation and cAMP signaling
Rinaldi, L., Sepe, M., Donne, R. D., & Feliciello, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00177 · Cited by 34
“Accordingly, dys-regulation of the UPS has been found in a wide array of human cancer (Landis et al., 1989; Weinstein et al., 1991; Palmer et al., 2000).”
BackgroundBrudnik, U., Branicki, W., Wojas‐Pelc, A., & Kanas, P. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00760.x · Cited by 33
Geffrotin, C., Créchet, F., Roy, P. L., Chalony, C. L., Leplat, J. J. J. J., Iannuccelli, N., Barbosa, A. S., Renard, C., Gruand, J., Milan, D., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20053 · Cited by 33
Genetic Mutations Involved in Melanoma: A Summary of Our Current Understanding
High, W. A., & Robinson, W. A. (2007) · Advances in Dermatology · doi:10.1016/j.yadr.2007.07.009 · Cited by 39
Flanagan, N., Ray, A. J., Todd, C., Birch‐Machin, M. A., & Rees, J. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01532.x · Cited by 35
Gupta, S., & Tsao, H. (2016) · Springer eBooks · doi:10.1007/978-3-319-35153-7_31 · Cited by 34
Martínez‐Cadenas, C., López, S., Ribas, G., Flores, C., García, O., Sevilla, A., Zubiaga, I. S., Ibarrola‐Villava, M., Pino-Yanes, M. D. M., Gardeazábal, J., et al. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst158 · Cited by 37
“…to find association between variants at MC1R (and other pigmentation genes) to melanoma risk (Valverde et al. 1996; Ichii-Jones et al. 1998; Palmer et al. 2000; Kennedy et al. 2001; Fernandez et al. 2007; Raimondi et al. 2008; Scherer et al. 2009; Williams et al. 2011; Davies et al. 2012).”
BackgroundAbrisqueta, M., Herráiz, C., Pérez‐Oliva, A. B., Sánchez‐Laorden, B. L., Olivares, C., Jiménez‐Cervantes, C., & García-Borrón, J. C. (2013) · Journal of Cell Science · doi:10.1242/jcs.128322 · Cited by 35
“Thus, carriers of hypomorphic MC1R variants normally display an inefficient or absent tanning response (Healy et al., 2000; Rees, 2004) and a higher risk of melanoma and non-melanoma skin cancer (Box et al., 1997; Box et al., 2001; Duffy et al., 2004; Duffy et al., 2010; Palmer et al., 2000).”
BackgroundFargnoli, M. C., Chimenti, S., Keller, G., Höfler, H., & Peris, K. (2003) · Human Mutation · doi:10.1002/humu.9150 · Cited by 34
“In addition, recent studies have shown a significant association between the MC1R genotype and both familial and sporadic melanoma (Palmer et al., 2000; Box et al., 2001b; Kennedy et al., 2001) as well as non-melanoma skin cancer (Box et al., 2001a).”
BackgroundArrayed identification of DNA signatures
Käller, M., Lundeberg, J., & Ahmadian, A. (2007) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.7.1.65 · Cited by 32
“A defined phenotype called the red hair color (RHC) phenotype has been associated to certain variants of MC1R (Valverde et al., 1996; Palmer et al., 2000; Kennedy et al., 2001) and to an increased risk of cutaneous malignant melanoma (Valverde et al.”
BackgroundThe Role of Melanocortins in Skin Homeostasis
Böhm, M., & Luger, T. A. (2000) · Hormone Research in Paediatrics · doi:10.1159/000053273 · Cited by 32
Hay, J. L., Berwick, M., Zielaskowski, K., White, K. A., Rodríguez, V. M., Robers, E., Guest, D. D., Sussman, A. L., Talamantes, Y., Schwartz, M., et al. (2017) · JMIR Research Protocols · doi:10.2196/resprot.7158 · Cited by 31
“Importantly, variation in MC1R is associated with melanoma risk after adjustment for hair color and skin type [32-34,40-42].”
Upadhyay, P. R., Starner, R. J., Swope, V. B., Wakamatsu, K., Ito, S., & Abdel-Malek, Z. A. (2022) · Antioxidants · doi:10.3390/antiox11061204 · Cited by 30
Therapeutic targeting of protein S-acylation for the treatment of disease
Fraser, N. J., Howie, J., Wypijewski, K. J., & Fuller, W. (2019) · Biochemical Society Transactions · doi:10.1042/bst20190707 · Cited by 33
“Several non-synonymous single nucleotide polymorphisms (SNPs) in the MC1R gene have been discovered, and a group of them termed red hair colour (RHC) variants are associated with red hair colour, fair skin and poor tanning ability as well as increased risk of developing melanoma [99-103].”
BackgroundDevelopment of an integrated method of skin phenotype measurement using the melanins
Zanetti, R., Prota, G., Napolitano, A., Martínez, C., Sancho-Garnier, H., Østerlind, A., Sacerdote, C., & Rosso, S. (2001) · Melanoma Research · doi:10.1097/00008390-200112000-00001 · Cited by 30
Fisler, J. S., & Warden, C. H. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391884-0.00023-8 · Cited by 29
Masoodi, T., Shammari, S. A. A., Al-Muammar, M. N., Alhamdan, A. A., & Talluri, V. R. (2012) · Gene · doi:10.1016/j.gene.2012.08.026 · Cited by 32
“validated the SIFT in MSHR gene and found that predicted tolerated substitutions L60V and R163Q by SIFT were in concordance with the experimental results (Palmer et al., 2000).”
ResultMC1R, ASIP, TYR, and TYRP1 gene variants in a population‐based series of multiple primary melanomas
Helsing, P., Nymoen, D. A., Rootwelt, H., Vårdal, M., Akslen, L. A., Molven, A., & Andresen, P. A. (2012) · Genes Chromosomes and Cancer · doi:10.1002/gcc.21952 · Cited by 32
“The risk of melanoma increases about two-fold for each RHC allele carried (Palmer et al., 2000).”
BackgroundInfluentialLatreille, J., Ezzedine, K., Elfakir, A., Ambroisine, L., Gardinier, S., Galan, P., Herçberg, S., Грубер, Ф., Rees, J., Tschachler, E., et al. (2009) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.2009.00594.x · Cited by 37
“UV-induced DNA damage, as previously reported for melanoma risk factor studies (11,12,15,33).”
BackgroundKoikov, L. N., Starner, R. J., Swope, V. B., Upadhyay, P. R., Hashimoto, Y., Freeman, K. T., Knittel, J. J., Haskell‐Luevano, C., & ABDEL‐MALEK, Z. A. (2021) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2020.11.034 · Cited by 29
“In the latter melanocytes, 1 was more potent, whereas 5 was effective, yet less potent than α-MSH (Supplementary Figure S2a).”
BackgroundInfluentialAvril, M.-F., Bahadoran, P., Cabaret, O., Caron, O., de la Fouchardière, A., Démenais, F., Desjardins, L., Frébourg, T., Hammel, P. R., Leccia, M. ‐., et al. (2014) · Annales de Dermatologie et de Vénéréologie · doi:10.1016/j.annder.2014.09.606 · Cited by 35
Models and mechanisms in malignant melanoma
Benjamin, C. L., Melnikova, V. O., & Ananthaswamy, H. N. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20353 · Cited by 33
“MC1R variants seem to influencemelanoma riskmainly through their effect on pigmentation characteristics such as red hair and fair skin that are associated with melanoma [36].”
BackgroundBiomarkers in melanoma: predisposition, screening and diagnosis
Carlson, J. A., Slominski, A. T., Linette, G. P., Mihm, M. C., & Ross, J. S. (2003) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.3.2.163 · Cited by 28
Guida, S., Ciardo, S., Pace, B. D., Carvalho, N. D., Peccerillo, F., Manfredini, M., Farnetani, F., Chester, J., Kaleci, S., Manganelli, M., et al. (2019) · Experimental Dermatology · doi:10.1111/exd.14037 · Cited by 28
BRAF Polymorphisms and Risk of Melanocytic Neoplasia
James, M. R., Roth, R. B., Shi, M. M., Kammerer, S., Nelson, M. R., Stark, M. S., Dumenil, T. D., Montgomery, G. W., Hayward, N. K., Martin, N. G., et al. (2005) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2005.23937.x · Cited by 27
“…an Australian case-control sample made up of 755 melanoma cases from 740 families participating in the QFMP (Aitken et al, 1994; Aitken et al, 1996; Palmer et al, 2000), and genotyped controls were 2239 individuals without melanoma from 635 twin families (476 DZ, 159 MZ) enrolled in the BTNS (Zhu…”
MethodSelf-citationCDKN2A and MC1R Mutations in Patients with Sporadic Multiple Primary Melanoma
Peris, K., Fargnoli, M. C., Pacifico, A., Surrenti, T., Stolz, W., Wolf, P., Soyer, H. P., & Chimenti, S. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.22532.x · Cited by 27
“Sturm, 2002 ) and an increased predisposition to melanoma development”
BackgroundAssociation Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk
Soufir, N., Meziani, R., Lacapère, J.-J., Bertrand, G., Fumeron, F., Bourillon, A., Gérard, B., Descamps, V., Crickx, B., Ollivaud, L., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji253 · Cited by 30
Kasparian, N. A., McLoone, J. K., Meiser, B., Butow, P. N., Simpson, J. M., & Mann, G. J. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605942 · Cited by 30
“…melanoma such as level of exposure to ultraviolet radiation (Cannon-Albright et al, 1994; Goldstein et al, 1998), skin pigmentation and freckling (Palmer et al, 2000; van der Velden et al, 2001), and potentially by modifier genes which may, in Received 7 May 2010; revised 9 September 2010;…”
BackgroundReview of High-Precision Sr Isotope Analyses of Low-Sr Geological Samples
Lin, J., Liu, Y., Chen, H., Zhou, L., Hu, Z., & Gao, S. (2015) · Journal of Earth Science · doi:10.1007/s12583-015-0593-0 · Cited by 26
“Sr spec TM resin can separate Sr from Ca and Ba completely (Scher et al., 2014; Palmer et al., 2000; Philip Horwitz et al., 1992) (Fig.”
BackgroundInfluentialThe MeLiM Minipig: An Original Spontaneous Model to Explore Cutaneous Melanoma Genetic Basis
Bourneuf, E. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00146 · Cited by 26
“Early studies have also designated MC1R as a low-risk gene (Valverde et al., 1996; Palmer et al., 2000).”
BackgroundCharacterization of melanocortin-1 receptor gene variants in uveal melanoma patients.
Metzelaar-Blok, J. A. W., ter Huurne, J. A., Hurks, H. M. H., KEUNEN, J. E. E., Jager, M. J., & Gruis, N. A. (2001) · PubMed · Cited by 26
Newton‐Bishop, J., Harland, M., & Bishop, D. T. (2006) · British Journal of Hospital Medicine · doi:10.12968/hmed.2006.67.6.21288 · Cited by 28
Ha, T., Naysmith, L., Waterston, K., Oh, C., Weller, R., & Rees, J. L. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03198.x · Cited by 31
Afamelanotide (CUV1647) in dermal phototoxicity of erythropoietic protoporphyria
Minder, E. I., & Schneider‐Yin, X. (2014) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2014.956089 · Cited by 26
Forensic DNA Phenotyping: Genes and Genetic Variants for Eye Color Prediction
Brancato, D., Coniglio, E., Bruno, F., Agostini, V., Saccone, S., & Federico, C. (2023) · Genes · doi:10.3390/genes14081604 · Cited by 28
“3 chromosomal band (Figure 3), coding for a melanocyte-stimulating hormone receptor (MSHR), a G protein-coupled transmembrane receptor that is highly polymorphic and responsible for intraspecific and interspecific color variation [62,63].”
BackgroundKasparian, N. A., Meiser, B., Butow, P. N., Job, R. F. S., & Mann, G. J. (2006) · Journal of Genetic Counseling · doi:10.1007/s10897-006-9038-3 · Cited by 25
“melanocortin receptor (MC1R) genotype, a major correlate of skin pigmentation and freckling (Palmer et al., 2000; van der Velden et al., 2001); and potentially by modifier genes which, in certain families, may also be associated with the presence of atypical nevi (Tucker et al.”
BackgroundCutaneous melanoma: pathogenesis and rationale for chemoprevention
Demierre, M., & Sondak, V. K. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.11.001 · Cited by 27
Fogarty, G. B., Muddle, R., Sprung, C. N., Chen, W., Duffy, D. L., Sturm, R. A., & McKay, M. J. (2009) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2009.07.1690 · Cited by 25
Self-citationConsiderations for Designing a Prototype Genetic Test for Use in Translational Research
Wade, C. H., McBride, C. M., Kardia, S. L. R., & Brody, L. C. (2009) · Public Health Genomics · doi:10.1159/000236061 · Cited by 25
Moody, M., Morrison, L. K., & Tyring, S. K. (2010) · PubMed · Cited by 31
John, P. R., & Ramsay, M. (2002) · Human Mutation · doi:10.1002/humu.9030 · Cited by 25
“Specific variants that have been found to be associated with the red hair and pale skin phenotype; R151C, R160W and D294H (Box et al., 1997; Smith et al., 1998) were found to be significantly associated with cutaneous malignant melanoma (CMM) (Palmer et al., 2000).”
BackgroundMelanocortin 1 receptor variants, pigmentation, and skin cancer susceptibility
Healy, E. (2004) · Photodermatology Photoimmunology & Photomedicine · doi:10.1111/j.1600-0781.2004.00132.x · Cited by 33
Hacker, E., Olsen, C. M., Kvaskoff, M., Pandeya, N., Yeo, A. J., Green, A. C., Williamson, R. M., Triscott, J., Wood, D., Mortimore, R. J., et al. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2015.12.035 · Cited by 25
“The melanocortin-1 receptor (MC1R) gene is a key determinant of human pigmentation with specific variants linked to red hair and melanoma risk (Palmer et al., 2000; Sturm et al., 2003).”
BackgroundSelf-citationEPAC–RAP1 Axis-Mediated Switch in the Response of Primary and Metastatic Melanoma to Cyclic AMP
Rodríguez, C. I., Castro‐Pérez, E., Prabhakar, K., Block, L., Longley, B. J., Wisinski, J. A., Kimple, M. E., & Setaluri, V. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0067 · Cited by 24
“Human MC1R gene polymorphisms that result in cAMP signaling impairment are associated with a fair skin and red hair color phenotype and increased risk of melanoma (2-4).”
Contributions byMC1RVariants to Melanoma Risk in Males and Females
Wendt, J., Mueller, C., Rauscher, S., Faé, I., Fischer, G., & Okamoto, I. (2018) · JAMA Dermatology · doi:10.1001/jamadermatol.2018.1252 · Cited by 25
Hansson, J. (2008) · Surgical Clinics of North America · doi:10.1016/j.suc.2008.04.005 · Cited by 32
“Although each RHC allele is associated with an approximately twofold risk for CMM, each individual may carry two or more RHC SNPs, which further increases the CMM risk [79].”
BackgroundRoberts, D. W., Newton, R. A., Leonard, J. H., & Sturm, R. A. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21318 · Cited by 24
“L I S S , I N C . predisposition for elevated skin cancer risk cannot be fully correlated with pigmentation phenotype (Healy et al., 2000; Palmer et al., 2000; Bastiaens et al., 2001; Kennedy et al., 2001) which suggests a genetic role for MC1R beyond pigmentation protection.”
BackgroundSelf-citationPhenotypic Expression of Melanocortin-1 Receptor Mutations in Black Jamaicans
Harding, R. M., Tomlinson, J. B., Ray, A. J., Wakamatsu, K., Rees, J. L., & McKenzie, C. A. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12314.x · Cited by 25
An overview of benefits and risks of chronic melanocortin‐1 receptor activation
Böhm, M., Robert, C., Malhotra, S., Clément, K., & Farooqi, I. S. (2024) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.20269 · Cited by 27
“55 Although many variants affect the signalling ability of MC1R, the red hair colour variants D84E, R142H, R151C, R160W and D294H—which are associated with complete or partial loss of function of the MC1R—are especially associated with increased melanoma risk.”
Variants of the melanocortin‐1 receptor: do they matter clinically?
Haddadeen, C., Lai, C., Cho, S., & Healy, E. (2014) · Experimental Dermatology · doi:10.1111/exd.12540 · Cited by 27
Quint, K. D., Rhee, J., Gruis, N. A., ter Huurne, J., Wolterbeek, R., van der Stoep, N., Bergman, W., & Kukutsch, N. A. (2012) · Acta Dermato Venereologica · doi:10.2340/00015555-1457 · Cited by 26
Nan, H., Qureshi, A. A., Hunter, D. J., & Han, J. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08624.x · Cited by 26
Cutaneous melanoma: family screening and genetic testing
Niendorf, K. B., & Tsao, H. (2006) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2005.00050.x · Cited by 23
New Insights into G-Protein-Coupled Receptor Signaling from the Melanocortin Receptor System
Rana, B. K. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.1.1 · Cited by 26
Pavey, S. J., & Gabrielli, B. G. (2002) · PubMed · Cited by 34
Melanogenic Effect of Dersimelagon (Mt-7117), a Novel Oral Melanocortin 1 Receptor Agonist
Suzuki, T., Kawano, Y., Matsumoto, A., Kondo, M., Funayama, K., Tanemura, S., Miyashiro, M., Nishi, A., Yamada, K., Tsuda, M., et al. (2021) · Skin Health and Disease · doi:10.1002/ski2.78 · Cited by 22
“Epidemiological evidence indicates that mutations in MC1R are genetic risk factors for melanoma in humans that are thought to act by loss of function.(20,21) The αMSH/MC1R agonism has a role of prevention of skin cancer including melanoma by up regulating two important photo‐protective mechanisms, DNA repair and pigme…”
BackgroundMutation load in melanoma is affected by MC 1R genotype
Johansson, P. A., Pritchard, A. L., Patch, A., Wilmott, J. S., Pearson, J. V., Waddell, N., Scolyer, R. A., Mann, G. J., & Hayward, N. K. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12571 · Cited by 22
Self-citationMasoodi, T., Talluri, V. R., Shaik, N. A., Al-Aama, J. Y., & Hasan, Q. A. (2012) · Genomics · doi:10.1016/j.ygeno.2012.04.006 · Cited by 22
de Araújo, É. S. S., Pramio, D. T., Kashiwabara, A. Y., Pennacchi, P. C., Maria–Engler, S. S., Achatz, M. I., Campos, A. H. J. F. M., Neto, J. P. D., Rosenberg, C., Carraro, D. M., et al. (2015) · BioMed Research International · doi:10.1155/2015/376423 · Cited by 22
“Beta-values were retrieved for all CpG probes mapped within DNA sequences associated with the BAP1, CDK4, CDKN2A, KIT,MC1R, MGMT,MITF, PALB2, POT1, TERT, TNF, and TNFRSF10C genes (see Supplementary Tables 1 and 2 in Supplementary Material available online at http://dx.doi.org/10.1155/2015/376423).”
BackgroundInfluentialEvolution of approaches to identify melanoma missing heritability
Dalmasso, B., & Ghiorzo, P. (2020) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2020.1738221 · Cited by 21
“nant or recessive manner depending on the variant, and the occurrence of melanoma [24].”
BackgroundResultThe Genes and Genetics of Malignant Melanoma
Gibbs, P., Brady, B., & Robinson, W. A. (2002) · Journal of Cutaneous Medicine and Surgery · doi:10.1007/s10227-001-0037-6 · Cited by 24
Dellavalle, R. P., Johnson, K. R., Hester, E. J., Deas, A. M., Mokrohisky, S. T., Morelli, J. G., & Crane, L. A. (2005) · Archives of Dermatology · doi:10.1001/archderm.141.8.1042 · Cited by 21
Guida, S., Bartolomeo, N., Zanna, P. T., Grieco, C., Maida, I., Summa, S. D., Tommasi, S., Guida, M., Azzariti, A., Foti, C., et al. (2015) · Archives of Dermatological Research · doi:10.1007/s00403-015-1552-4 · Cited by 22
“RHC variants are known to be associated with fair skin, red hair, poor tanning ability and melanoma [13, 34].”
BackgroundGenetics: What Advice for Patients Who Present With a Family History of Melanoma?
Newton‐Bishop, J., & Gruis, N. A. (2007) · Seminars in Oncology · doi:10.1053/j.seminoncol.2007.09.006 · Cited by 26
Johanson, H. C., Chen, W., Wicking, C., & Sturm, R. A. (2009) · Journal of Human Genetics · doi:10.1038/jhg.2009.130 · Cited by 19
Self-citationRisk factors for the development of primary cutaneous malignant melanoma
MacKie, R. M. (2002) · Dermatologic Clinics · doi:10.1016/s0733-8635(02)00028-1 · Cited by 19
Re: Association Between Endothelin Receptor B Nonsynonymous Variants and Melanoma Risk
Thirumaran, R. K., Thoelke, A., Ugurel, S., Hemminki, K., Schadendorf, D., & Kumar, R. (2006) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djj336 · Cited by 19
Metadata
- Authors
- Palmer, J. S., Duffy, D. L., Box, N. F., Aitken, J. F., O'Gorman, L. E., Green, A. C., Hayward, N. K., Martin, N. G., & Sturm, R. A.
- Affiliations
- The University of Queensland (AU)
- Corresponding author
- Sturm, Richard A.
- ORCID
- Venue
- The American Journal of Human Genetics
- Publisher
- Elsevier BV
- Published
- 2000-01
- Volume
- 66
- Issue
- 1
- Pages
- 176-186
- ISSN
- 0002-9297 (ISSN-L)
- PMC
- PMC1288324
- OpenAlex
- W2115022580
- Cited by
- 503
- References
- 42
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 8 · 2023: 4 · 2022: 4 · 2021: 12 · 2020: 11 · 2019: 9 · 2018: 11 · 2017: 16 · 2016: 22 · 2015: 6 · 2014: 19 · 2013: 23 · 2012: 21
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4948 d)
- Locations
- The American Journal of Human Genetics (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Menzies School of Health Research
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › melanin and skin pigmentation
- Health Sciences › Medicine › Oncology › Cutaneous Melanoma Detection and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Keywords
- MC1R, cutaneous melanoma, melanoma risk, skin color, hair color, freckling, nevus count, sun exposure, genetic susceptibility
- MeSH terms
- Data Interpretation, Statistical, Eye Color, Female, Genotype, Hair Color, Humans, Male, Melanoma, Phenotype, Pigmentation, Polymorphism, Genetic, Risk Factors, Skin Pigmentation, Genetic Variation, Linkage Disequilibrium, Polymerase Chain Reaction, Receptors, Corticotropin, Receptors, Melanocortin, White People
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.